Real-world utilization and safety of ipilimumab plus nivolumab (I plus N) in metastatic renal cell carcinoma (mRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Thana, Myuran
  • Basappa, Naveen S
  • Ghosh, Sunita
  • Kollmannsberger, Christian K
  • Heng, Daniel Yick Chin
  • Graham, Jeffrey
  • Soulieres, Denis
  • Hansen, Aaron Richard
  • Lalani, Aly-Khan
  • Castonguay, Vincent
  • Reaume, M Neil
  • Bjarnason, Georg A
  • Breau, Rodney H
  • Pouliot, Frederic
  • Kapoor, Anil
  • Wood, Lori

publication date

  • February 20, 2020